HTHSCI 1DT3 Lecture Notes - Lecture 13: Antioxidant, Pulmonary Heart Disease, Salbutamol

• School: McMaster University
• Department: Health Sciences
• Course: HTHSCI 1DT3
• Professor: Carl Richards

Document Summary

Mod. 1-16 gold guidelines - relationship to clinical management in copd 1. Mod. 1-16 gold guidelines relationship to clinical management in copd. Introduction: gold global initiative for chronic obstructive lung disease. Increase awareness of copd among health professionals, health authorities, and the general public. Improve diagnosis, management and prevention of copd: stimulate research in copd, classification of copd severity by spirometry (gold 2008 & nice guideline 2010, stage 1: mild. Fev1 80% predicted: stage 2: moderate. 50% fev1 < 80% predicted: stage 3: severe. 30% fev1 < 50% predicted: stage 4: very severe. Fev1 < 30% predicted: there are four components of copd management (see headings) Normal value is 80%: patients are usually older and have comorbidities (other diseases) that should be identified. Values should be compared to age-related normal values to avoid over-diagnosis of copd: differential diagnosis. Symptoms vary from day to day, and at night/early morning. Mod. 1-16 gold guidelines - relationship to clinical management in copd 2.